Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
TCRR

TCR2 Therapeutics

$15.95

(0.00%)

, BBDC

Barings BDC

$9.85

0.04 (0.41%)

10:27
03/11/19
03/11
10:27
03/11/19
10:27
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

TCRR

TCR2 Therapeutics

$15.95

(0.00%)

BBDC

Barings BDC

$9.85

0.04 (0.41%)

AVDR

Avedro

$11.50

-0.25 (-2.13%)

ANCN

Anchiano Therapeutics

$7.66

(0.00%)

CTMX

CytomX Therapeutics

$9.57

0.07 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 12

    Mar

  • 21

    Mar

ANCN

Anchiano Therapeutics

$7.66

-0.02 (-0.26%)

09:19
03/11/19
03/11
09:19
03/11/19
09:19
Initiation
Anchiano Therapeutics initiated at Ladenburg »

Anchiano Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCN

Anchiano Therapeutics

$7.66

-0.02 (-0.26%)

07:06
03/11/19
03/11
07:06
03/11/19
07:06
Initiation
Anchiano Therapeutics initiated at Oppenheimer »

Anchiano Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCN

Anchiano Therapeutics

$0.00

(0.00%)

10:07
02/12/19
02/12
10:07
02/12/19
10:07
Syndicate
Anchiano Therapeutics opens at $11.50, IPO priced at $11.50 per share »

Anchiano Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

ANCN

Anchiano Therapeutics

$0.00

(0.00%)

09:14
02/12/19
02/12
09:14
02/12/19
09:14
Syndicate
Anchiano Therapeutics 2.6M share IPO priced at $11.50 »

Oppenheimer acted as lead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.